前列腺特异性抗原反应检测不到比卡鲁胺停药现象。

Techniques in urology Pub Date : 2000-09-01

E A El-Gabry, S E Strup, L G Gomella

{"title":"前列腺特异性抗原反应检测不到比卡鲁胺停药现象。","authors":"E A El-Gabry, S E Strup, L G Gomella","doi":"","DOIUrl":null,"url":null,"abstract":"Several reports have described the antiandrogen withdrawal syndrome with various nonsteroidal antiandrogen agents. To our knowledge, there have been no reports describing a durable undetectable prostate-specific antigen (PSA) response with discontinuation of the antiandrogen agent bicalutamide (Casodex, Zeneca, Wilmington, DE, U.S.A.). We report a case in which a decline of serum PSA to undetectable levels was achieved with bicalutamide discontinuation.","PeriodicalId":79536,"journal":{"name":"Techniques in urology","volume":"6 3","pages":"221-2"},"PeriodicalIF":0.0000,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon.\",\"authors\":\"E A El-Gabry, S E Strup, L G Gomella\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Several reports have described the antiandrogen withdrawal syndrome with various nonsteroidal antiandrogen agents. To our knowledge, there have been no reports describing a durable undetectable prostate-specific antigen (PSA) response with discontinuation of the antiandrogen agent bicalutamide (Casodex, Zeneca, Wilmington, DE, U.S.A.). We report a case in which a decline of serum PSA to undetectable levels was achieved with bicalutamide discontinuation.\",\"PeriodicalId\":79536,\"journal\":{\"name\":\"Techniques in urology\",\"volume\":\"6 3\",\"pages\":\"221-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2000-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Techniques in urology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Techniques in urology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

一些报告描述了各种非甾体抗雄激素药物的抗雄激素戒断综合征。据我们所知，目前还没有关于停止使用抗雄激素药物比卡鲁胺(Casodex, Zeneca, Wilmington, DE, usa)后出现持久的无法检测到的前列腺特异性抗原(PSA)反应的报道。我们报告了一个病例，其中血清PSA下降到不可检测的水平是实现比卡鲁胺停药。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon.

Several reports have described the antiandrogen withdrawal syndrome with various nonsteroidal antiandrogen agents. To our knowledge, there have been no reports describing a durable undetectable prostate-specific antigen (PSA) response with discontinuation of the antiandrogen agent bicalutamide (Casodex, Zeneca, Wilmington, DE, U.S.A.). We report a case in which a decline of serum PSA to undetectable levels was achieved with bicalutamide discontinuation.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Techniques in urology

自引率

0.00%

发文量